Tango Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $7.9M | — |
| Mar 2020 | — | $417.0K | — |
| Jun 2020 | — | $22.2M | $25.0K |
| Sep 2020 | — | $46.9M | $1.6M |
| Dec 2020 | — | $38.6M | $28.4M |
| Mar 2021 | — | $57.9M | $1.3M |
| Jun 2021 | — | $54.9M | $582.9K |
| Sep 2021 | — | $365.4M | $205.0M |
| Dec 2021 | — | $344.7M | $142.7M |
| Mar 2022 | — | $320.4M | $99.9M |
| Jun 2022 | — | $298.7M | $104.6M |
| Sep 2022 | — | $273.1M | $100.3M |
| Dec 2022 | — | $249.5M | $60.0M |
| Mar 2023 | — | $227.3M | $57.3M |
| Jun 2023 | — | $212.9M | $66.1M |
| Sep 2023 | — | $276.6M | $58.5M |
| Dec 2023 | — | $253.1M | $66.4M |
| Mar 2024 | — | $264.5M | $61.2M |
| Jun 2024 | — | $247.7M | $51.6M |
| Sep 2024 | — | $229.2M | $53.1M |
| Dec 2024 | — | $199.5M | $69.5M |
| Mar 2025 | — | $166.8M | $58.4M |
| Jun 2025 | — | $135.0M | $39.3M |
| Sep 2025 | — | $160.0M | $58.3M |
| Dec 2025 | — | $346.2M | $112.3M |
| Mar 2026 | — | $391.5M | $157.8M |
| Jun 2026 | — | $1.02B | $345.6M |